Almost all of the shares offered in Ambea’s SKr1.2bn (US$124.8m) two-for-five rights issue have been taken up. The largest care provider in the Nordic region said that 99.9% of the shares on offer have been subscribed for. And there were more than double the applications for subscription without subscription rights. Ambea has sold up to…